Toll-like receptors — taking an evolutionary approach. Nature Reviews Genetics 9, 165–178 (2008) doi:10.1038/nrg2303. Liu, L. et al. Structural basis of Toll-like receptor 3 signaling with ...

Miracure Biotechnology Ltd. has divulged Toll-like receptor 7 (TLR7) and/or TLR8 agonists reported to be useful for the treatment of cancer, infections, respiratory disorders and immunological ...

Toll-like receptor. Toll-like receptors (TLRs) are one of the largest and best-studied families of pattern-recognition receptors of the innate immune system. TLRs recognize pathogen- and danger ...

This is a toll-like receptor. We will go into a little bit more about what that what's TLR agonist is about. It's an immunotherapy drug candidate called Intellimod. And we acquired a license for ...

However, Blander and Medzhitov also revisit our paper in which we reported no influence of TLR signaling on phagosome ... on the idea that some phagocytic receptors are 'more equal than others'.

This expansion of commercial rights is part of the license agreement with Statera Biopharma for its late-stage Toll-like Receptor 5 (TLR5 ... license for the TLR5 agonist program Entolimod ...

The company announced that they had acquired worldwide exclusive license rights to a late-stage Toll-like Receptor 5 (TLR5) agonist for the treatment of acute radiation syndrome. The news sparked ...